Condition: Parkinson Disease · Sponsor: Azienda Sanitaria Universitaria Integrata del Trentino
The goal of the present study is to explore the diagnostic and prognostic value of neurophysiological biomarkers obtained through paired-pulse Transcranial Magnetic Stimulation (TMS) techniques in individuals affected by Parkinson's disease (PD) with and without cognitive decline. The main questions it aims to answer are: * TMS measures of cortical excitability are able to distinguish between PD patients cognitively normal, PD-Mild Cognitive Impairment (PD-MCI) and PD-Dementia (PD-D)? * TMS measures of cortical excitability are able to predict progression of PD patient cognitive status from cognitively normal to PD-MCI and PD-D?
This description comes directly from the study's public registry record.
Ruggero Bacchin, MD · +39-0461903281 · ruggero.bacchin@apss.tn.it
Stefania Campostrini, MSc · +39-0461903281 · stefania.campostrini@apss.tn.it
Always discuss trial participation with your own doctor first.
| SC Clinica Neurologica - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Trieste, Friuli Venezia Giulia, Italy | Not Yet Recruiting |
| UOC Neuroriabilitazione - Azienda Sanitaria dell'Alto Adige | Sterzing, Trentino-Alto Adige, Italy | Not Yet Recruiting |
| UOC Neurologia - Azienda Provinciale per i Servizi Sanitari (APSS) | Trento, Trentino-Alto Adige, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06835595